Effect of foot-electroshock stress on cholinergic activity, tissue glycogen and blood sugar in albino rats.
The immediate or 24 hr delayed effects of 1-day (1-DS) or (7-DS) foot-electroshock stress in albino rats were studied on cardiac acetylcholine (ACh), blood and cardiac cholinesterase (ChE) activities, cardiac, hepatic and muscle glycogen contents and blood sugar concentrations. The effects of physostigmine (PHY), atropine, 6-hydroxydopamine (6-HD), vagotomy and adrenalectomy on 1-DS induced changes were also studied.  1-DS produced an increase in cardiac ACh content which lasted for 24 hr but repeated stress showed phenomenon of adaptation. There seems to be activation of autonomic cholinergic system in stress. 1-DS and 7-DS produced a short-lived inhibition of blood ChE activity and 7-DS also of cardiac ChE activity. Inhibition of ChE activity was probably related to release of adrenaline from adrenal medulla. 1-DS produced hepatic and muscle glycogenolysis with slight hypoglycaemia but without any effect on cardiac glycogen. Following repeated stress there was a phenomenon of adaptation. The hepatic and muscle glycogenolysis produced by stress is due to the release of adrenaline from adrenal medulla. Normally functioning cardiac cholinergic system seems to have a protective effect on heart against stress, in the absence of which cardiac glycogenolysis is induced by stress.
D000109:Acetylcholine / Q000032:analysis*; D000315:Adrenalectomy; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis*; D002802:Cholinesterases / Q000378:metabolism*; D004597:Electroshock; D005121:Extremities; D005260:Female; D006003:Glycogen / Q000032:analysis*; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000032:analysis*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D013315:Stress, Psychological / Q000502:physiology*; D014628:Vagotomy
D001786:Blood Glucose; D006892:Hydroxydopamines; D001285:Atropine; D006003:Glycogen; D010830:Physostigmine; D002802:Cholinesterases; D000109:Acetylcholine